APO Research
Talk to an analyst

APO RESEARCH · REPORT

Teriflunomide Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Research

Teriflunomide Tablets Industry Research Report 2026

27 December 2025133 pages

Choose your research edition.

Industry ResearchTeriflunomide Tablets Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Teriflunomide Tablets Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Teriflunomide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Teriflunomide Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Teriflunomide Tablets Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Teriflunomide Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Teriflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Teriflunomide Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Teriflunomide Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Teriflunomide Tablets include Teva, CGeneTech (Suzhou, China), Nanjing Healthnice Pharmaceutical, Mylan, Cisen Pharmaceutical, Zydus, Viatris, SOLA Pharmaceuticals and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Teriflunomide Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Teriflunomide Tablets Market by Company

Teva

CGeneTech (Suzhou, China)

Nanjing Healthnice Pharmaceutical

Mylan

Cisen Pharmaceutical

Zydus

Viatris

SOLA Pharmaceuticals

Sanofi

Sandoz

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

Camber Pharmaceuticals

Aurobindo Pharma

Apotex

Alembic

Accord Healthcare

Teriflunomide Tablets Segment by Type

7mg per Tablet

14mg per Tablet

Teriflunomide Tablets Segment by Application

Hospital and Clinic

Pharmacy

Other

Teriflunomide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teriflunomide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Teriflunomide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teriflunomide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Teriflunomide Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Teriflunomide Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Teriflunomide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Teriflunomide Tablets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Teriflunomide Tablets Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Teriflunomide Tablets Sales Market Share by Manufacturers (2021-2026) Table 8. Global Teriflunomide Tablets Revenue of Manufacturers (2021-2026) Table 9. Global Teriflunomide Tablets Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Teriflunomide Tablets Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Teriflunomide Tablets Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Teriflunomide Tablets, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Teriflunomide Tablets, Product Type & Application Table 14. Global Teriflunomide Tablets Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Teriflunomide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Company Information Table 19. Teva Business Overview Table 20. Teva Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Teva Teriflunomide Tablets Product Portfolio Table 22. Teva Recent Developments Table 23. CGeneTech (Suzhou, China) Company Information Table 24. CGeneTech (Suzhou, China) Business Overview Table 25. CGeneTech (Suzhou, China) Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. CGeneTech (Suzhou, China) Teriflunomide Tablets Product Portfolio Table 27. CGeneTech (Suzhou, China) Recent Developments Table 28. Nanjing Healthnice Pharmaceutical Company Information Table 29. Nanjing Healthnice Pharmaceutical Business Overview Table 30. Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Product Portfolio Table 32. Nanjing Healthnice Pharmaceutical Recent Developments Table 33. Mylan Company Information Table 34. Mylan Business Overview Table 35. Mylan Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Mylan Teriflunomide Tablets Product Portfolio Table 37. Mylan Recent Developments Table 38. Cisen Pharmaceutical Company Information Table 39. Cisen Pharmaceutical Business Overview Table 40. Cisen Pharmaceutical Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Cisen Pharmaceutical Teriflunomide Tablets Product Portfolio Table 42. Cisen Pharmaceutical Recent Developments Table 43. Zydus Company Information Table 44. Zydus Business Overview Table 45. Zydus Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Zydus Teriflunomide Tablets Product Portfolio Table 47. Zydus Recent Developments Table 48. Viatris Company Information Table 49. Viatris Business Overview Table 50. Viatris Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Viatris Teriflunomide Tablets Product Portfolio Table 52. Viatris Recent Developments Table 53. SOLA Pharmaceuticals Company Information Table 54. SOLA Pharmaceuticals Business Overview Table 55. SOLA Pharmaceuticals Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. SOLA Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 57. SOLA Pharmaceuticals Recent Developments Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sanofi Teriflunomide Tablets Product Portfolio Table 62. Sanofi Recent Developments Table 63. Sandoz Company Information Table 64. Sandoz Business Overview Table 65. Sandoz Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sandoz Teriflunomide Tablets Product Portfolio Table 67. Sandoz Recent Developments Table 68. Glenmark Pharmaceuticals Company Information Table 69. Glenmark Pharmaceuticals Business Overview Table 70. Glenmark Pharmaceuticals Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Glenmark Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 72. Glenmark Pharmaceuticals Recent Developments Table 73. Dr. Reddy's Laboratories Company Information Table 74. Dr. Reddy's Laboratories Business Overview Table 75. Dr. Reddy's Laboratories Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Dr. Reddy's Laboratories Teriflunomide Tablets Product Portfolio Table 77. Dr. Reddy's Laboratories Recent Developments Table 78. Camber Pharmaceuticals Company Information Table 79. Camber Pharmaceuticals Business Overview Table 80. Camber Pharmaceuticals Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Camber Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 82. Camber Pharmaceuticals Recent Developments Table 83. Aurobindo Pharma Company Information Table 84. Aurobindo Pharma Business Overview Table 85. Aurobindo Pharma Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Aurobindo Pharma Teriflunomide Tablets Product Portfolio Table 87. Aurobindo Pharma Recent Developments Table 88. Apotex Company Information Table 89. Apotex Business Overview Table 90. Apotex Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Apotex Teriflunomide Tablets Product Portfolio Table 92. Apotex Recent Developments Table 93. Alembic Company Information Table 94. Alembic Business Overview Table 95. Alembic Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Alembic Teriflunomide Tablets Product Portfolio Table 97. Alembic Recent Developments Table 98. Accord Healthcare Company Information Table 99. Accord Healthcare Business Overview Table 100. Accord Healthcare Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Accord Healthcare Teriflunomide Tablets Product Portfolio Table 102. Accord Healthcare Recent Developments Table 103. Global Teriflunomide Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Teriflunomide Tablets Sales by Region (2021-2026) & (K Units) Table 105. Global Teriflunomide Tablets Sales Market Share by Region (2021-2026) Table 106. Global Teriflunomide Tablets Sales by Region (2027-2032) & (K Units) Table 107. Global Teriflunomide Tablets Sales Market Share by Region (2027-2032) Table 108. Global Teriflunomide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Teriflunomide Tablets Revenue Market Share by Region (2021-2026) Table 110. Global Teriflunomide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Teriflunomide Tablets Revenue Market Share by Region (2027-2032) Table 112. North America Teriflunomide Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 114. North America Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 115. North America Teriflunomide Tablets Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Teriflunomide Tablets Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Teriflunomide Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 119. Europe Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 120. Europe Teriflunomide Tablets Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Teriflunomide Tablets Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Teriflunomide Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Teriflunomide Tablets Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Teriflunomide Tablets Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Teriflunomide Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 129. South America Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 130. South America Teriflunomide Tablets Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Teriflunomide Tablets Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Teriflunomide Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Teriflunomide Tablets Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Teriflunomide Tablets Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Teriflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 138. Global Teriflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 139. Global Teriflunomide Tablets Sales Market Share by Type (2021-2026) Table 140. Global Teriflunomide Tablets Sales Market Share by Type (2027-2032) Table 141. Global Teriflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Teriflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Teriflunomide Tablets Revenue Market Share by Type (2021-2026) Table 144. Global Teriflunomide Tablets Revenue Market Share by Type (2027-2032) Table 145. Global Teriflunomide Tablets Price by Type (2021-2026) & (US$/Unit) Table 146. Global Teriflunomide Tablets Price by Type (2027-2032) & (US$/Unit) Table 147. Global Teriflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 148. Global Teriflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 149. Global Teriflunomide Tablets Sales Market Share by Application (2021-2026) Table 150. Global Teriflunomide Tablets Sales Market Share by Application (2027-2032) Table 151. Global Teriflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Teriflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Teriflunomide Tablets Revenue Market Share by Application (2021-2026) Table 154. Global Teriflunomide Tablets Revenue Market Share by Application (2027-2032) Table 155. Global Teriflunomide Tablets Price by Application (2021-2026) & (US$/Unit) Table 156. Global Teriflunomide Tablets Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Teriflunomide Tablets Distributors List Table 160. Teriflunomide Tablets Customers List Table 161. Teriflunomide Tablets Industry Trends Table 162. Teriflunomide Tablets Industry Drivers Table 163. Teriflunomide Tablets Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Teriflunomide Tablets Product Image Figure 5. Global Teriflunomide Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Teriflunomide Tablets Market Size (2021-2032) & (US$ Million) Figure 7. Global Teriflunomide Tablets Sales (2021-2032) & (K Units) Figure 8. Global Teriflunomide Tablets Average Price (US$/Unit) & (2021-2032) Figure 9. 7mg per Tablet Product Image Figure 10. 14mg per Tablet Product Image Figure 11. Hospital and Clinic Product Image Figure 12. Pharmacy Product Image Figure 13. Other Product Image Figure 14. Global Teriflunomide Tablets Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Teriflunomide Tablets, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Teriflunomide Tablets Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Teriflunomide Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Teriflunomide Tablets Sales by Region in 2025 Figure 20. Global Teriflunomide Tablets Revenue by Region in 2025 Figure 21. North America Teriflunomide Tablets Market Size by Country in 2025 Figure 22. North America Teriflunomide Tablets Sales Market Share by Country (2021-2032) Figure 23. North America Teriflunomide Tablets Revenue Market Share by Country (2021-2032) Figure 24. United States Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Teriflunomide Tablets Market Size by Country in 2025 Figure 28. Europe Teriflunomide Tablets Sales Market Share by Country (2021-2032) Figure 29. Europe Teriflunomide Tablets Revenue Market Share by Country (2021-2032) Figure 30. Germany Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Teriflunomide Tablets Market Size by Country in 2025 Figure 41. Asia Pacific Teriflunomide Tablets Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Teriflunomide Tablets Revenue Market Share by Country (2021-2032) Figure 43. China Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Teriflunomide Tablets Market Size by Country in 2025 Figure 52. South America Teriflunomide Tablets Sales Market Share by Country (2021-2032) Figure 53. South America Teriflunomide Tablets Revenue Market Share by Country (2021-2032) Figure 54. Brazil Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Teriflunomide Tablets Market Size by Country in 2025 Figure 58. Middle East and Africa Teriflunomide Tablets Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Teriflunomide Tablets Revenue Market Share by Country (2021-2032) Figure 60. Egypt Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Teriflunomide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Teriflunomide Tablets Sales Market Share by Type (2021-2032) Figure 66. Global Teriflunomide Tablets Revenue Market Share by Type (2021-2032) Figure 67. Global Teriflunomide Tablets Price (US$/Unit) by Type (2021-2032) Figure 68. Global Teriflunomide Tablets Sales Market Share by Application (2021-2032) Figure 69. Global Teriflunomide Tablets Revenue Market Share by Application (2021-2032) Figure 70. Global Teriflunomide Tablets Price (US$/Unit) by Application (2021-2032) Figure 71. Teriflunomide Tablets Value Chain Figure 72. Teriflunomide Tablets Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Teriflunomide Tablets Industry Opportunities and Challenges

Scope & coverage.

Types
  • 7mg per Tablet
  • 14mg per Tablet
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Teva
  • CGeneTech (Suzhou, China)
  • Nanjing Healthnice Pharmaceutical
  • Mylan
  • Cisen Pharmaceutical
  • Zydus
  • Viatris
  • SOLA Pharmaceuticals
  • Sanofi
  • Sandoz
  • Glenmark Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Camber Pharmaceuticals
  • Aurobindo Pharma
  • Apotex
  • Alembic
  • Accord Healthcare

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Teriflunomide Tablets Market Size (2021-2032)
  4. 2.2.2 Global Teriflunomide Tablets Sales (2021-2032)
  5. 2.2.3 Global Teriflunomide Tablets Market Average Price (2021-2032)
  6. 2.3 Teriflunomide Tablets by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 7mg per Tablet
  9. 2.3.3 14mg per Tablet
  10. 2.4 Teriflunomide Tablets by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital and Clinic
  13. 2.4.3 Pharmacy
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Teriflunomide Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Teriflunomide Tablets Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Teriflunomide Tablets Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Teriflunomide Tablets Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Teriflunomide Tablets Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Teriflunomide Tablets, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Teriflunomide Tablets, Product Type & Application
  8. 3.8 Global Manufacturers of Teriflunomide Tablets, Established Date
  9. 3.9 Global Teriflunomide Tablets Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva
  2. 4.1.1 Teva Company Information
  3. 4.1.2 Teva Business Overview
  4. 4.1.3 Teva Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Teriflunomide Tablets Product Portfolio
  6. 4.1.5 Teva Recent Developments
  7. 4.2 CGeneTech (Suzhou, China)
  8. 4.2.1 CGeneTech (Suzhou, China) Company Information
  9. 4.2.2 CGeneTech (Suzhou, China) Business Overview
  10. 4.2.3 CGeneTech (Suzhou, China) Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 CGeneTech (Suzhou, China) Teriflunomide Tablets Product Portfolio
  12. 4.2.5 CGeneTech (Suzhou, China) Recent Developments
  13. 4.3 Nanjing Healthnice Pharmaceutical
  14. 4.3.1 Nanjing Healthnice Pharmaceutical Company Information
  15. 4.3.2 Nanjing Healthnice Pharmaceutical Business Overview
  16. 4.3.3 Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Product Portfolio
  18. 4.3.5 Nanjing Healthnice Pharmaceutical Recent Developments
  19. 4.4 Mylan
  20. 4.4.1 Mylan Company Information
  21. 4.4.2 Mylan Business Overview
  22. 4.4.3 Mylan Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Mylan Teriflunomide Tablets Product Portfolio
  24. 4.4.5 Mylan Recent Developments
  25. 4.5 Cisen Pharmaceutical
  26. 4.5.1 Cisen Pharmaceutical Company Information
  27. 4.5.2 Cisen Pharmaceutical Business Overview
  28. 4.5.3 Cisen Pharmaceutical Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Cisen Pharmaceutical Teriflunomide Tablets Product Portfolio
  30. 4.5.5 Cisen Pharmaceutical Recent Developments
  31. 4.6 Zydus
  32. 4.6.1 Zydus Company Information
  33. 4.6.2 Zydus Business Overview
  34. 4.6.3 Zydus Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Zydus Teriflunomide Tablets Product Portfolio
  36. 4.6.5 Zydus Recent Developments
  37. 4.7 Viatris
  38. 4.7.1 Viatris Company Information
  39. 4.7.2 Viatris Business Overview
  40. 4.7.3 Viatris Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Viatris Teriflunomide Tablets Product Portfolio
  42. 4.7.5 Viatris Recent Developments
  43. 4.8 SOLA Pharmaceuticals
  44. 4.8.1 SOLA Pharmaceuticals Company Information
  45. 4.8.2 SOLA Pharmaceuticals Business Overview
  46. 4.8.3 SOLA Pharmaceuticals Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 SOLA Pharmaceuticals Teriflunomide Tablets Product Portfolio
  48. 4.8.5 SOLA Pharmaceuticals Recent Developments
  49. 4.9 Sanofi
  50. 4.9.1 Sanofi Company Information
  51. 4.9.2 Sanofi Business Overview
  52. 4.9.3 Sanofi Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sanofi Teriflunomide Tablets Product Portfolio
  54. 4.9.5 Sanofi Recent Developments
  55. 4.10 Sandoz
  56. 4.10.1 Sandoz Company Information
  57. 4.10.2 Sandoz Business Overview
  58. 4.10.3 Sandoz Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sandoz Teriflunomide Tablets Product Portfolio
  60. 4.10.5 Sandoz Recent Developments
  61. 4.11 Glenmark Pharmaceuticals
  62. 4.11.1 Glenmark Pharmaceuticals Company Information
  63. 4.11.2 Glenmark Pharmaceuticals Business Overview
  64. 4.11.3 Glenmark Pharmaceuticals Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Glenmark Pharmaceuticals Teriflunomide Tablets Product Portfolio
  66. 4.11.5 Glenmark Pharmaceuticals Recent Developments
  67. 4.12 Dr. Reddy's Laboratories
  68. 4.12.1 Dr. Reddy's Laboratories Company Information
  69. 4.12.2 Dr. Reddy's Laboratories Business Overview
  70. 4.12.3 Dr. Reddy's Laboratories Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Dr. Reddy's Laboratories Teriflunomide Tablets Product Portfolio
  72. 4.12.5 Dr. Reddy's Laboratories Recent Developments
  73. 4.13 Camber Pharmaceuticals
  74. 4.13.1 Camber Pharmaceuticals Company Information
  75. 4.13.2 Camber Pharmaceuticals Business Overview
  76. 4.13.3 Camber Pharmaceuticals Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Camber Pharmaceuticals Teriflunomide Tablets Product Portfolio
  78. 4.13.5 Camber Pharmaceuticals Recent Developments
  79. 4.14 Aurobindo Pharma
  80. 4.14.1 Aurobindo Pharma Company Information
  81. 4.14.2 Aurobindo Pharma Business Overview
  82. 4.14.3 Aurobindo Pharma Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Aurobindo Pharma Teriflunomide Tablets Product Portfolio
  84. 4.14.5 Aurobindo Pharma Recent Developments
  85. 4.15 Apotex
  86. 4.15.1 Apotex Company Information
  87. 4.15.2 Apotex Business Overview
  88. 4.15.3 Apotex Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Apotex Teriflunomide Tablets Product Portfolio
  90. 4.15.5 Apotex Recent Developments
  91. 4.16 Alembic
  92. 4.16.1 Alembic Company Information
  93. 4.16.2 Alembic Business Overview
  94. 4.16.3 Alembic Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Alembic Teriflunomide Tablets Product Portfolio
  96. 4.16.5 Alembic Recent Developments
  97. 4.17 Accord Healthcare
  98. 4.17.1 Accord Healthcare Company Information
  99. 4.17.2 Accord Healthcare Business Overview
  100. 4.17.3 Accord Healthcare Teriflunomide Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Accord Healthcare Teriflunomide Tablets Product Portfolio
  102. 4.17.5 Accord Healthcare Recent Developments
5 Global Teriflunomide Tablets Market Scenario by Region
  1. 5.1 Global Teriflunomide Tablets Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Teriflunomide Tablets Sales by Region: 2021-2032
  3. 5.2.1 Global Teriflunomide Tablets Sales by Region: 2021-2026
  4. 5.2.2 Global Teriflunomide Tablets Sales by Region: 2027-2032
  5. 5.3 Global Teriflunomide Tablets Revenue by Region: 2021-2032
  6. 5.3.1 Global Teriflunomide Tablets Revenue by Region: 2021-2026
  7. 5.3.2 Global Teriflunomide Tablets Revenue by Region: 2027-2032
  8. 5.4 North America Teriflunomide Tablets Market Facts & Figures by Country
  9. 5.4.1 North America Teriflunomide Tablets Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Teriflunomide Tablets Sales by Country (2021-2032)
  11. 5.4.3 North America Teriflunomide Tablets Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Teriflunomide Tablets Market Facts & Figures by Country
  16. 5.5.1 Europe Teriflunomide Tablets Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Teriflunomide Tablets Sales by Country (2021-2032)
  18. 5.5.3 Europe Teriflunomide Tablets Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Teriflunomide Tablets Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Teriflunomide Tablets Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Teriflunomide Tablets Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Teriflunomide Tablets Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Teriflunomide Tablets Market Facts & Figures by Country
  41. 5.7.1 South America Teriflunomide Tablets Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Teriflunomide Tablets Sales by Country (2021-2032)
  43. 5.7.3 South America Teriflunomide Tablets Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Teriflunomide Tablets Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Teriflunomide Tablets Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Teriflunomide Tablets Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Teriflunomide Tablets Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Teriflunomide Tablets Sales by Type (2021-2032)
  2. 6.1.1 Global Teriflunomide Tablets Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Teriflunomide Tablets Sales Market Share by Type (2021-2032)
  4. 6.2 Global Teriflunomide Tablets Revenue by Type (2021-2032)
  5. 6.2.1 Global Teriflunomide Tablets Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Teriflunomide Tablets Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Teriflunomide Tablets Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Teriflunomide Tablets Sales by Application (2021-2032)
  2. 7.1.1 Global Teriflunomide Tablets Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Teriflunomide Tablets Sales Market Share by Application (2021-2032)
  4. 7.2 Global Teriflunomide Tablets Revenue by Application (2021-2032)
  5. 7.2.1 Global Teriflunomide Tablets Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Teriflunomide Tablets Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Teriflunomide Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Teriflunomide Tablets Value Chain Analysis
  2. 8.1.1 Teriflunomide Tablets Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Teriflunomide Tablets Production Mode & Process
  5. 8.2 Teriflunomide Tablets Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Teriflunomide Tablets Distributors
  8. 8.2.3 Teriflunomide Tablets Customers
9 Global Teriflunomide Tablets Analyzing Market Dynamics
  1. 9.1 Teriflunomide Tablets Industry Trends
  2. 9.2 Teriflunomide Tablets Industry Drivers
  3. 9.3 Teriflunomide Tablets Industry Opportunities and Challenges
  4. 9.4 Teriflunomide Tablets Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst